Weinstein, Zoe M. https://orcid.org/0000-0002-8116-6023
Bratberg, Jeffrey
Joudrey, Paul J.
Fiellin, David A.
Funding for this research was provided by:
National Institute on Drug Abuse (UG1 DA01583)
Article History
Received: 3 June 2025
Accepted: 31 October 2025
First Online: 11 November 2025
Declarations
:
: Not applicable.
: Dr. Weinstein serves as the site medical director for a BayMark methadone clinic, with her employer, Boston University, paid a per diem rate for her time. Dr. Weinstein reported honorarium payment for serving as a member of the three advisory committees outside of the submitted work: the Producing Outcome Measures for OTP Quality Improvement (PROMOTe-QI) Health Professional Advisory Committee (from RTI International and the UCLA, funding from the National Institute on Drug Abuse), the National Coalition to Liberate Methadone, Post Conference Working Group (funded by the PEW Foundation), and the Pharmacy-Centered Methadone Access in North Carolina Clinical Advisory Board (funded through the NC Collaboratory). No other disclosures were reported.
Free to read: This content has been made available to all.